Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Epstein-Barr virus and multiple sclerosis.

Jan D Lünemann1, Christian Münz

  • 1Laboratory of Viral Immunobiology, Christopher H. Browne Center for Immunology and Immune Diseases, The Rockefeller University, Box 390, 1230 York Avenue, New York, NY 10021-6399, USA. jlunemann@rockefeller.edu

Current Neurology and Neuroscience Reports
|May 10, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phenotype, Severity, and Therapy of Patients With LRP4 Antibody-Associated Myasthenia Gravis in the German Myasthenia Gravis Registry.

Neurology·2026
Same author

Epstein-Barr virus and multiple sclerosis: from associations to mechanisms to potential therapies.

The Lancet. Neurology·2026
Same author

Proinflammatory Epstein-Barr Virus Antibody Functions Track with Disease Activity in Multiple Sclerosis.

Annals of neurology·2026
Same author

Rogue clones: When MS autoimmunity goes viral.

Science immunology·2026
Same author

Meningococcal prophylaxis in neurological diseases treated with complement inhibitors: an expert consensus for Germany, Austria, and Switzerland.

Therapeutic advances in neurological disorders·2026
Same author

Multicentric prognostic observational study on biomarker profile in immunotherapy-naïve patients with highly active generalized myasthenia gravis (PROGNO-MG): a study protocol.

Neurological research and practice·2026
Same journal

Update on Genetic Chorea.

Current neurology and neuroscience reports·2026
Same journal

Gastrointestinal Dysfunction in Critically Ill Patients With Traumatic Brain Injury: Clinical Implications and Putative Mechanisms: a Narrative Review.

Current neurology and neuroscience reports·2026
Same journal

The Potential of Rehabilitation to Amplify Experience-Induced Myelin Plasticity and Remyelination in Multiple Sclerosis: A Narrative Review.

Current neurology and neuroscience reports·2026
Same journal

The Noradrenergic Brain in Parkinson's Disease.

Current neurology and neuroscience reports·2026
Same journal

Mapping the Silent Onset of Parkinson's Disease: Monoamine Imaging in the Era of the Race for Preclinical Intervention.

Current neurology and neuroscience reports·2026
Same journal

Functional and Structural Brain Imaging Correlates of Treatment Response in Functional Movement Disorder.

Current neurology and neuroscience reports·2026
See all related articles

Epstein-Barr virus (EBV) infection may trigger autoimmune diseases like multiple sclerosis (MS) by altering immune responses. Understanding this link could lead to new EBV-targeted therapies for autoimmunity.

Area of Science:

  • Immunology
  • Virology
  • Autoimmunity

Background:

  • Epstein-Barr virus (EBV) infects over 90% of adults, typically remaining latent.
  • A balance between the immune system and EBV usually prevents disease.
  • This balance appears altered in autoimmune diseases, with heightened responses to EBV antigens.

Purpose of the Study:

  • To investigate the potential role of EBV in initiating and progressing autoimmune diseases.
  • To explore how EBV influences autoimmune B and T-cell responses.
  • To identify EBV-targeting strategies for autoimmune disease treatment.

Main Methods:

  • Analysis of immune responses to EBV-encoded antigens in patients with autoimmune diseases.
  • Investigation of EBV's B cell immortalization capabilities.

Related Experiment Videos

  • Examination of T-cell responses and cytokine profiles in persistent EBV infection.

    • Main Results:

    • Patients with MS and other autoimmune diseases exhibit enhanced and less restricted T-cell and antibody responses to EBV.
    • EBV possesses the ability to immortalize B cells and continuously stimulate T-cell responses.
    • Distinct immune responses suggest a role for EBV in autoimmunity.

    Conclusions:

    • EBV may promote autoimmune B and T-cell responses through direct stimulation, increased survival, molecular mimicry, and cytokine milieu.
    • Understanding EBV's interaction with autoimmunity can inform novel therapeutic strategies.
    • Targeting EBV could offer new avenues for preventing and treating autoimmune diseases.